Triple Negative Breast Cancer and Brain Metastases
Rani Bansal(Duke Medical Center), Carey K. Anders(Duke University), Amanda E.D. Van Swearingen(Duke Cancer Institute)
Cited by 13
Related Papers
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
|Journal of Clinical Oncology|2008|917
Breast Cancer Before Age 40 Years
|Seminars in Oncology|2009|795
Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
|Clinical Breast Cancer|2009|644